COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,043 Articles (22,627 medRxiv, 8,416 bioRxiv)

Most recent first Previous |  Page 85: Articles 841-850  | Next

SARS-CoV-2 Aggregated Activity Level Across Ontario Canada, Measured with the US CDC Wastewater Viral Activity Level (WVAL) Metric
Delatolla, R., DeGroot, C. T., McKay, R. M., Servos, M. R., McAvoy, S., Krishnakumar, S., Jo, O., Fung, M., Hegazy, S., Fletcher, T., Simhon, A., Pileggi, V.
10.1101/2025.02.07.25321887 — Posted: 2025-02-10
Glycosylphosphatidylinositol biosynthesis restricts coronavirus infection via the regulation of LY6E
Ma, Y., Feng, F., Feng, H., Ma, X., Wang, Z., Han, Y., Zhu, Y., Wang, Y., Gao, Z., Zhang, Y., Zhao, J., Zhang, R.
10.1101/2025.02.08.637211 — Posted: 2025-02-10
SARS-CoV-2 infection of the brain: the K18-hACE2 mouse model to illustrate the role and response of the vasculature in neurotropic viral infection
De Neck, S., Penrice-Randal, R., Hetzel, U., Seehusen, F., Sharma, P., Bentley, E. G., Helminger, B., Kirby, A., Balistreri, G., Stewart, J. P., Kipar, A.
10.1101/2025.02.07.637145 — Posted: 2025-02-08
The physio-affective symptoms of Long COVID are strongly predicted by the severity of the acute infectious phase, and lowered antioxidants, nitric oxide, and alanine transaminase levels.
Maes, M., Tunvirachaisakul, C., Semeao, L. d. O., Michelin, A. P., Matsumoto, A. K., Brinholi, F. F., Barbosa, D. S., Zhang, Y., Sodsai, P., Hirankarn, N., Almulla, A. F.
10.1101/2025.02.07.25321870 — Posted: 2025-02-08
Vaccine Effectiveness Among 5- to 17-year-old Individuals with Prior SARS-CoV-2 Infection: An EHR-Based Target Trial Emulation Study from the RECOVER Project
Chen, J., Lei, Y., Wu, Q., Zhou, T., Zhang, B., Becich, M. J., Bisyuk, Y., Blecker, S., Chrischilles, E. A., Christakis, D. A., Cowell, L. G., Cummins, M. R., Fernandez, S. A., Fort, D., Gonzalez, S., Herring, S. J., Horne, B. D., Horowitz, C., Liu, M., Kim, S., Mirhaji, P., Mosa, A. S. M., Muszynski, J. A., Paules, C. I., Sato, A., Schwenk, H. T., Sengupta, S., Suresh, S., Taylor, B. W., Williams, D. A., He, Y., Morris, J. S., Jhaveri, R., Forrest, C. B., Chen, Y.
10.1101/2025.02.07.25321814 — Posted: 2025-02-08
Longitudinal epigenetic rewiring in lung immune cells in patients with post-COVID-19 condition
Nikesjö, F., Smiljanic, J., Sayyab, s., Martinez-Enguita, D., Gustafsson, M., Rosvall, M., Hedman, K., Lerm, M.
10.1101/2025.02.06.25321750 — Posted: 2025-02-07
AVERTED MORTALITY BY COVID-19 VACCINATION IN BELGIUM BETWEEN 2021 AND 2023
Stouten, V., Van Evercooren, I., Vernemmen, C., Braeye, T., Catteau, L., Roelants, M., Billuart, M., Lamot, T., Bustos Sierra, N., Hammami, N., Vermeiren, E., Rosas, A., Blot, K., Schmelz, A. I., Nasiadka, L., Nganda, S., van Loenhout, J. A. F.
10.1101/2025.02.06.25321208 — Posted: 2025-02-07
'Trans-differentiation of neutrophils from plasmablast' is an artefact caused by over-reliance on machine algorithms in single cell RNA sequencing analysis: Lesson learnt and steps ahead
Huang, J., Yam, P. S. C., Tang, N. L.-s.
10.1101/2025.02.07.636761 — Posted: 2025-02-07
DAZAP2 functions as a pan-coronavirus restriction factor by inhibiting viral entry and genomic replication
Feng, F., Chen, J., Li, R., Zhu, Y., Ma, Y., Wang, Z., Wang, Y., Gao, Z., Yang, L., Yu, Y., Liu, Y., Sun, Y., Liao, Y., Huang, X., Zhang, Q., Huang, Y., Qiu, L., Wu, J., Zhao, J., Liu, C., Ding, Q., Xie, Y., Yuan, Z., Hong, Y., Zhang, P., Sun, J., Zhao, J., Zhang, R.
10.1101/2025.02.04.636569 — Posted: 2025-02-07
Reproducibility of Genetic Risk Factors Identified for Long COVID using Combinatorial Analysis Across US and UK Patient Cohorts with Diverse Ancestries
Sardell, J., Pearson, M., Chocian, K., Das, S., Taylor, K., Strivens, M., Gupta, R., Rochlin, A., Gardner, S.
10.1101/2025.02.04.25320937 — Posted: 2025-02-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).